Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8992220 | 0.84 | ALDH1A1 (0.58) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL16298656 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL8992209 | 0.78 | ALDH1A1 (0.65) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL8992490 | 0.77 | ALDH1A1 (0.54) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL7639 | 0.76 | ALDH1A1 (1.00) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL473081 | 0.76 | ALDH1A1 (1.00) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL10649685 | 0.76 | — | — | |
| Methyl Alcohol SCHEMBL28639806 | 0.74 | ALDH1A1 (0.79) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| Hydrochloric Acid SCHEMBL23581954 | 0.73 | ALDH1A1 (0.92) | ALDH1A1TSHRHDAC8TDP1TP53 | |
| SCHEMBL22496003 | 0.73 | ALDH1A1 (0.92) | ALDH1A1TSHRHDAC8TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10029117-B2 | Systems and methods for interior energy-activation from an exterior source | IMMUNOLIGHT, LLC (US) | 2018-07-24 | — | — | US | claimed |
| US-9630022-B2 | Plasmonic assisted systems and methods for interior energy-activation from an exterior source | IMMUNOLIGHT, LLC. (US) | 2017-04-25 | — | — | US | claimed |
| US-9278331-B2 | Systems and methods for interior energy-activation from an exterior source | IMMUNOLIGHT, LLC (US) | 2016-03-08 | — | — | US | claimed |
| US-20150290614-A1 | SYSTEMS AND METHODS FOR INTERIOR ENERGY-ACTIVATION FROM AN EXTERIOR SOURCE | IMMUNOLIGHT, LLC. (US) | 2015-10-15 | — | — | US | claimed |
| US-20150182934-A1 | SYSTEMS AND METHODS FOR INTERIOR ENERGY-ACTIVATION FROM AN EXTERIOR SOURCE | IMMUNOLIGHT, LLC. (US) | 2015-07-02 | — | — | US | claimed |
| US-8927615-B2 | Plasmonic assisted systems and methods for interior energy-activation from an exterior source | IMMUNOLIGHT, LLC (US) | 2015-01-06 | — | — | US | claimed |
| US-20140163303-A1 | PLASMONIC ASSISTED SYSTEMS AND METHODS FOR INTERIOR ENERGY-ACTIVATION FROM AN EXTERIOR SOURCE | DUKE UNIVERSITY (US) | 2014-06-12 | — | — | US | claimed |
| US-20130240758-A1 | PLASMONIC ASSISTED SYSTEMS AND METHODS FOR INTERIOR ENERGY-ACTIVATION FROM AN EXTERIOR SOURCE | IMMUNOLIGHT, LLC (US) | 2013-09-19 | — | — | US | claimed |
| US-5516871-A | Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof | DOW CORNING ASIA, LTD. (JP) | 1996-05-14 | — | — | US | claimed |
| US-5502229-A | ENDCAPPING | DOW CORNING ASIA, LTD. (JP) | 1996-03-26 | — | — | US | claimed |
| JP-8127657-A | — | — | None | — | — | JP | disclosed |
| CN-119978228-A | Preparation method of flexible material for violent sorting and high-temperature early warning in fire material evidence transportation | 应急管理部沈阳消防研究所 | 2025-05-13 | — | — | CN | disclosed |
| CN-119708755-A | Self-healing type fire physical evidence logistics transportation buffer material and preparation method thereof | 应急管理部沈阳消防研究所 | 2025-03-28 | — | — | CN | disclosed |
| EP-2711075-B1 | Plasmonic assisted systems and methods for interior energy-activation from an exterior source. | IMMUNOLIGHT LLC (US) | 2024-05-22 | — | — | EP | disclosed |
| US-20240042233-A1 | TUMOR IMAGING WITH X-RAYS AND OTHER HIGH ENERGY SOURCES USING AS CONTRAST AGENTS PHOTON-EMITTING PHOSPHORS HAVING THERAPEUTIC PROPERTIES | IMMUNOLIGHT, LLC (US) | 2024-02-08 | — | — | US | disclosed |
| US-6051625-A | Ultraviolet-curable polysiloxane composition and method for the formation of cured patterns therefrom | DOW CORNING ASIA, LTD. (JP) | 2000-04-18 | — | — | US | disclosed |
| EP-0816419-A2 | Ultraviolet-curable polysiloxane composition and method for the formation of cured patterns therefrom | DOW CORNING ASIA, Ltd. (JP) | 1998-01-07 | — | — | EP | disclosed |
| JP-H08127657-A | PRODUCTION OF CURED DIPHENYLSILOXANE AND CURED PRODUCT | DOW CORNING ASIA LTD | 1996-05-21 | — | — | JP | disclosed |
| US-5516871-A | Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof | DOW CORNING ASIA, LTD. (JP) | 1996-05-14 | — | — | US | disclosed |
| US-5502229-A | ENDCAPPING | DOW CORNING ASIA, LTD. (JP) | 1996-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240042233-A1 | TUMOR IMAGING WITH X-RAYS AND OTHER HIGH ENERGY SOURCES USING AS CONTRAST AGENTS PHOTON-EMITTING PHOSPHORS HAVING THERAPEUTIC PROPERTIES | P2RY1, PYGL, P2RX1 | ALDH1A1 4355/4885TSHR 370/4885HDAC8 4136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.